Nalaganje...
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
BACKGROUND: Patients with giant cell arteritis (GCA) treated with tocilizumab (TCZ) every week or every other week and prednisone tapering achieved superior rates of sustained remission to patients treated with placebo and prednisone tapering in a randomised controlled trial. Health-related quality...
Shranjeno v:
| izdano v: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6381622/ https://ncbi.nlm.nih.gov/pubmed/30786937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1837-7 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|